Apple Hit with $634M Penalty in Smartwatch Patent Case
A federal jury ruled that Apple must pay $634 million for infringing patents related to smartwatch technology in a landmark decision. The verdict, one of the largest in patent history, could reshape the wearable tech industry.
What Led to the Lawsuit?
Medical tech company Masimo Corporation sued Apple, claiming the tech giant stole its blood-oxygen monitoring tech for the Apple Watch Series 6 and later models without permission. Masimo alleged that after discussing a potential partnership, Apple used its patented innovation anyway.
The jury found Apple guilty of willful infringement, awarding $394 million in royalties and $240 million in punitive damages.
Apple’s Defense & Why the Jury Ruled Against Them
Apple denied wrongdoing, arguing its blood-oxygen sensor was independently developed and that Masimo’s patents were too broad. However, the jury determined Apple knowingly infringed, leading to the massive penalty.
How This Affects Apple & the Smartwatch Market
The Apple Watch’s blood-oxygen tracking, a key feature since 2020, could be at risk. Potential outcomes include:
– Removal of the feature if an injunction forces Apple to stop using Masimo’s tech.
– A licensing deal between Apple and Masimo.
– Reputation damage for Apple in the health-tech sector.
Bigger Impact on the Tech Industry
This case highlights rising patent conflicts in wearables, where companies integrate medical tech for competitive advantages. Legal experts warn firms to verify third-party tech rights before implementation.
“This ruling proves courts won’t tolerate patent theft, especially in health tech,” says IP lawyer Rajesh Mehta.
What’s Next?
Apple will likely appeal, prolonging the case. Meanwhile, Masimo celebrates the win as a victory for innovation.
Key Takeaways
- One of the largest patent fines in tech history.
- Could force changes to Apple Watch features.
- May encourage more patent lawsuits against tech giants.
📢 Follow us for updates on Apple’s appeal and smartwatch developments.
